The US Food and Drug Administration has approved PTC Therapeutics’ oral drug to treat a rare inherited metabolic disorder that prevents the body from properly breaking down certain amino acids, the company said on Monday. The approval allows PTC to expand its revenue base as its top-selling Duchenne muscular dystrophy therapies, Translarna and Emflaza, face…
New Delhi: Women who use a combined oral contraceptive (COC)—better known as the pill—are three times more likely to suffer an unexpected stroke than those who don’t. These new findings were presented at a conference of European Stroke Organisation in Finland’s Helsinki on May 20.The pill is a hormonal contraceptive, containing both oestrogen and progestogen,…
Dr Krishna Ella executive chairman Bharat Biotech HYDERABAD: Vaccine maker Bharat Biotech on Wednesday said its oral cholera vaccine, Hillchol, successfully completed Phase III clinical trials demonstrating efficacy against both Ogawa and Inaba serotypes.The Hyderabad-based vaccine maker said Hillchol showed an over four-fold rise in vibriocidal antibodies—68.3% for Ogawa and 69.5% for Inaba serotypes. The…